Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/6510
Title: Presence of CD34+ in Megakaryocytes in Association With p53 Expression Predicts Unfavorable Prognosis in Low-risk Myelodysplastic Syndrome Patients
Authors: Santos, Talyta Ellen de Jesus dos
Duarte, Fernando Barroso
Barbosa, Maritza Cavalcante
Moura, Anna Thawanny Gadelha
Vasconcelos, João Paulo Leitão de
Rocha-Filho, Francisco Dário
Coutinho, Diego Ferreira
Vasconcelos, Paulo R. L.
Garcia, Yhasmine Delles Oliveira
Lemes, Romélia Pinheiro Gonçalves
Renault, Ilana Zalcberg
Keywords: Síndromes Mielodisplásicas
Myelodysplastic Syndromes
Antígenos CD34
Antigens, CD34
Megacariócitos
Megakaryocytes
Proteína Supressora de Tumor p53
Tumor Suppressor Protein p53
Prognóstico
Prognosis
Issue Date: 2019
Publisher: In vivo
Abstract: Background/Aim: Although risk stratification using the Prognostic Scores Systems (IPSS, WPSS and IPSSR) incorporate key information about prognosis of patients with Myelodysplastic syndromes (MDS), patients classified as low-risk may evolve rapidly and aggressively, despite a “favorable” prognostic stratification. The aim of this study was to identify biomarkers for predicting prognosis, and for better stratification and management of these patients. Materials and Methods: Expression of CD34 and p53 in megakaryocytes was examined by immunohistochemistry in 71 MDS patients classified as low-risk. Results: CD34 staining in megakaryocytes was associated with p53 expression (p=0.0166). CD34 and p53 expression were associated to worse overall survival in patients (p=0.0281). Conclusion: The presence of CD34 in megakaryocytes is associated with p53 expression and an adverse prognosis for MDS patients
URI: http://sr-vmlxaph03:8080/jspui/handle/123456789/6510
ISSN: 1791-7549
Appears in Collections:Artigo de Periódicos da Pesquisa Clínica

Files in This Item:
File Description SizeFormat 
in_vivo-33-277.pdf158.15 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.